Vatn M H, Grimstad I A, Thorsen L, Kittang E, Refnin I, Malt U, Løvik A, Langeland T, Naalsund A
Medical Department A, Rikshospitalet, Oslo, Norway.
Digestion. 1995;56(5):421-8. doi: 10.1159/000201270.
Double-blind placebo-controlled food challenge (DBPCFC) with food items applied in capsules was performed in a prospective study of 17 selected patients and 34 age- and sex-matched healthy controls in the interdisciplinary clinical setting. Protein immunoblotting showed no differences in antigenicity between foods in the capsules and the corresponding fresh foods. All patients reacted to one or more food substances during DBPCFC, with a doubtful reaction to placebo in 2 patients. Agreement between diet history and provocation was seen in 53 of 85 individual food challenges, 36 being positive with both examinations. In 22 (38%) of the 58 positive provocations, the reactions were not expected from the patients' histories. No reaction to food or placebo occurred in the control group. Related to diet history, sensitivity and specificity of provocation were 62 and 63%, respectively, with a positive predictive value of 78%. Allergy, previous gastroenterologic and infectious diseases among first-degree relatives, immunologic abnormalities and elevation of total IgE were significantly more common for the patients than controls. A positive skin prick test correlated well with diet history, but both prick test and food antibodies correlated poorly with DBPCFC. Assessment by the General Health Questionnaire showed a significant difference towards the controls. After 3-4 months of follow-up on an individually based diet, 11 of 15 patients reported general improvement of their condition. DBPCFC may be a valuable diagnostic test in addition to dietary history as a basis for elimination diet on food-intolerant patients. The effect of the elimination diet on the symptoms may also suggest a therapeutic effect or provocation.(ABSTRACT TRUNCATED AT 250 WORDS)
在跨学科临床环境中,对17例选定患者和34例年龄及性别匹配的健康对照者进行了前瞻性研究,采用胶囊形式的食物进行双盲安慰剂对照食物激发试验(DBPCFC)。蛋白质免疫印迹显示,胶囊中的食物与相应新鲜食物之间的抗原性无差异。所有患者在DBPCFC期间对一种或多种食物物质有反应,2例患者对安慰剂有可疑反应。在85次个体食物激发试验中,53次饮食史与激发试验结果相符,36次两项检查均为阳性。在58次阳性激发试验中的22次(38%)中,患者病史中未预期到这些反应。对照组对食物或安慰剂无反应。与饮食史相关,激发试验的敏感性和特异性分别为62%和63%,阳性预测值为78%。患者的过敏、一级亲属中的既往胃肠病和传染病、免疫异常以及总IgE升高明显比对照组更常见。阳性皮肤点刺试验与饮食史相关性良好,但点刺试验和食物抗体与DBPCFC的相关性均较差。一般健康问卷评估显示患者与对照组有显著差异。在基于个体饮食的3 - 4个月随访后,15例患者中有11例报告病情总体改善。除饮食史外,DBPCFC可能是一种有价值的诊断试验,可作为食物不耐受患者排除饮食的依据。排除饮食对症状的影响也可能提示治疗效果或激发作用。(摘要截短至250字)